Literature DB >> 10770259

Incidence and long-term prognosis of initial stroke and acute myocardial infarction in Okinawa, Japan.

K Fukiyama1, Y Kimura, K Wakugami, H Muratani.   

Abstract

We performed a cross-sectional survey of the incidence of stroke and acute myocardial infarction (AMI) in Okinawa, Japan, with a census population of about 1.2 million. A total of 3,644 cases of first-ever stroke and 898 cases of initial AMI were detected. The age-adjusted annual incidence rate of stroke was 105 per 100,000 of the standard population of Japan based on census population taken in 1985, and that of AMI was 26 per 100,000. The case-fatality rate of stroke within 28 days of onset was 12.8%, and that of AMI was 22.2%. Of the stroke cases, 51.4% were diagnosed as brain infarctions, 38.7% as brain hemorrhages, and 9.3% as subarachnoid hemorrhages. The diagnoses of stroke subtypes were confirmed by computed tomography or magnetic resonance imaging in 98.4% of all stroke cases. The long-term prognosis of patients with stroke and AMI was studied by examining their 10-yr survival rates (follow-up rate 89.8%). The cumulative survival rate was 38.2% in brain infarction cases, 40.4% in brain hemorrhage cases, and 38.2% in AMI cases. The 50% reduction of survival had occurred at 2,880 days after onset in brain infarction cases, at 2,764 days in brain hemorrhage cases, and at 2,658 days in AMI cases. In Okinawa, the incidence rate of AMI was still considerably lower than that in the Western population, and the rate of stroke was similar to that in the Western population. The ten-year survival rates were quite similar in AMI and stroke, and both were unexpectedly high.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770259     DOI: 10.1291/hypres.23.127

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  5 in total

1.  Cost-effectiveness of chronic kidney disease mass screening test in Japan.

Authors:  Masahide Kondo; Kunihiro Yamagata; Shu-ling Hoshi; Chie Saito; Koichi Asahi; Toshiki Moriyama; Kazuhiko Tsuruya; Hideaki Yoshida; Kunitoshi Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2011-12-14       Impact factor: 2.801

2.  Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease.

Authors:  Reiko Okubo; Masahide Kondo; Shu-ling Hoshi; Kunihiro Yamagata
Journal:  Sleep Breath       Date:  2015-02-03       Impact factor: 2.816

3.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

Review 4.  Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: a meta-analysis.

Authors:  Qian Xu; Yunfan Tian; Hao Peng; Hongmei Li
Journal:  Hypertens Res       Date:  2016-12-01       Impact factor: 3.872

5.  Established risk factors account for most of the racial differences in cardiovascular disease mortality.

Authors:  Sean O Henderson; Christopher A Haiman; Lynne R Wilkens; Laurence N Kolonel; Peggy Wan; Malcolm C Pike
Journal:  PLoS One       Date:  2007-04-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.